X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with Panacea Biotech - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK LTD vs PANACEA BIOTECH - Comparison Results

MERCK LTD    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

PANACEA BIOTECH 
   Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK LTD PANACEA BIOTECH MERCK LTD/
PANACEA BIOTECH
 
P/E (TTM) x 27.1 79.5 34.2% View Chart
P/BV x 3.0 1.8 172.1% View Chart
Dividend Yield % 0.9 0.0 -  

Financials

 MERCK LTD   PANACEA BIOTECH
EQUITY SHARE DATA
    MERCK LTD
Dec-16
PANACEA BIOTECH
Mar-14
MERCK LTD/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs1,060149 712.8%   
Low Rs62382 757.0%   
Sales per share (Unadj.) Rs632.484.1 751.6%  
Earnings per share (Unadj.) Rs45.7-18.3 -249.7%  
Cash flow per share (Unadj.) Rs62.3-6.7 -930.2%  
Dividends per share (Unadj.) Rs11.000-  
Dividend yield (eoy) %1.30-  
Book value per share (Unadj.) Rs388.883.7 464.5%  
Shares outstanding (eoy) m16.6061.25 27.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.31.4 96.9%   
Avg P/E ratio x18.4-6.3 -291.8%  
P/CF ratio (eoy) x13.5-17.2 -78.3%  
Price / Book Value ratio x2.21.4 156.9%  
Dividend payout %24.10-   
Avg Mkt Cap Rs m13,9697,074 197.5%   
No. of employees `0001.62.8 57.6%   
Total wages/salary Rs m1,4871,449 102.6%   
Avg. sales/employee Rs Th6,631.91,874.1 353.9%   
Avg. wages/employee Rs Th939.2527.0 178.2%   
Avg. net profit/employee Rs Th479.4-407.7 -117.6%   
INCOME DATA
Net Sales Rs m10,4985,154 203.7%  
Other income Rs m242100 242.9%   
Total revenues Rs m10,7415,254 204.4%   
Gross profit Rs m1,135-766 -148.2%  
Depreciation Rs m276711 38.7%   
Interest Rs m01,503 0.0%   
Profit before tax Rs m1,102-2,881 -38.3%   
Minority Interest Rs m011 0.0%   
Prior Period Items Rs m0-6 0.0%   
Extraordinary Inc (Exp) Rs m01,771 0.0%   
Tax Rs m34317 2,043.5%   
Profit after tax Rs m759-1,121 -67.7%  
Gross profit margin %10.8-14.9 -72.7%  
Effective tax rate %31.1-0.6 -5,340.4%   
Net profit margin %7.2-21.8 -33.2%  
BALANCE SHEET DATA
Current assets Rs m6,4103,810 168.2%   
Current liabilities Rs m8,8288,365 105.5%   
Net working cap to sales %-23.0-88.4 26.1%  
Current ratio x0.70.5 159.4%  
Inventory Days Days58156 37.0%  
Debtors Days Days3867 57.1%  
Net fixed assets Rs m1,40614,480 9.7%   
Share capital Rs m16661 270.8%   
"Free" reserves Rs m6,286903 696.0%   
Net worth Rs m6,4555,127 125.9%   
Long term debt Rs m05,832 0.0%   
Total assets Rs m8,82819,433 45.4%  
Interest coverage xNM-0.9-  
Debt to equity ratio x01.1 0.0%  
Sales to assets ratio x1.20.3 448.4%   
Return on assets %8.62.0 437.7%  
Return on equity %11.8-21.9 -53.8%  
Return on capital %17.13.6 469.6%  
Exports to sales %8.324.5 33.8%   
Imports to sales %21.010.2 206.7%   
Exports (fob) Rs m8691,264 68.8%   
Imports (cif) Rs m2,209525 421.0%   
Fx inflow Rs m9591,539 62.3%   
Fx outflow Rs m2,612942 277.3%   
Net fx Rs m-1,653597 -276.8%   
CASH FLOW
From Operations Rs m1,070599 178.6%  
From Investments Rs m-750-438 171.2%  
From Financial Activity Rs m-150-303 49.5%  
Net Cashflow Rs m171-141 -120.9%  

Share Holding

Indian Promoters % 0.0 74.5 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 18.2 0.6 3,033.3%  
FIIs % 1.0 1.3 76.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 23.6 123.3%  
Shareholders   28,591 10,259 278.7%  
Pledged promoter(s) holding % 0.0 35.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK LTD With:   CIPLA  PIRAMAL ENTERPRISES  NATCO PHARMA  SUN PHARMA  PFIZER  

Compare MERCK LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Green; Lupin up 4%(01:30 pm)

After opening the day flat, share markets in India remained rangebound and are presently trading marginally above the dotted line.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

Dear PM Modi, India is Already Land of Self-Employed, and It Ain't Working(Vivek Kaul's Diary)

Aug 21, 2017

Most Indians who cannot find jobs, look at becoming self-employed.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Think Twice Before You Keep Money In A Savings Bank Account(Outside View)

Aug 22, 2017

Post demonetisation, a cut in bank savings deposits rates was in the offing.

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MERCK LTD SHARE PRICE


Aug 24, 2017 02:27 PM

TRACK MERCK LTD

  • Track your investment in MERCK LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MERCK LTD - ABBOTT INDIA COMPARISON

COMPARE MERCK LTD WITH

MARKET STATS